CONTRACT MANUFACTURING AGREEMENT AMONG ONYX PHARMACEUTICALS, INC., ONYX PHARMACEUTICALS INTERNATIONAL GMBH AND CAMBRIDGE MAJOR LABORATORIES, INC. CONFIDENTIALContract Manufacturing Agreement • February 28th, 2013 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Contract Manufacturing Agreement (the “Agreement”) is entered into as of the 25th day of June, 2012 (“Effective Date”) by and among CAMBRIDGE MAJOR LABORATORIES, INC., a Wisconsin corporation, having its principal address at W130 N10497 Washington Drive, Germantown, Wisconsin 53022 (“CAMBRIDGE”), ONYX PHARMACEUTICALS, INC., a Delaware corporation, having its principal place of business at 249 East Grand Avenue, South San Francisco, Califomia 94080 and ONYX PHARMACEUTICALS INTERNATIONAL GMBH, a Swiss limited liability corporation, having its principal place of business at Dammstrasse 19, 6300 Zug, Switzerland (collectively, herein referred to as “ONYX”). CAMBRIDGE and ONYX may each be referred to herein as a “Party” and collectively, the “Parties.”
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. CONTRACT...Contract Manufacturing and Supply Agreement • February 28th, 2013 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This CONTRACT MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) is made effective as of this 3rd day of July, 2012 (the “Effective Date”), by and among DSM Pharmaceuticals, Inc., a Delaware corporation with principal place of business at 5900 Martin Luther King Hwy, Greenville, North Carolina 27834 (“DSM”), Onyx Pharmaceuticals, Inc., a Delaware corporation with principal place of business at 249 East Grand Avenue, South San Francisco, California 94080, and Onyx Pharmaceuticals International GmbH, a Swiss corporation with principal place of business at Dammstrasse 19, 6300 Zug Switzerland (collectively, “Onyx”); (each individually a “Party” and collectively the “Parties”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • February 28th, 2013 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Contract Manufacturing Agreement (“Agreement”) is entered into and made effective as of the 29th day of August, 2012 (“Effective Date”) by and between Onyx Pharmaceuticals International GmbH, a wholly-owned subsidiary of Onyx Pharmaceuticals, Inc. (“Onyx”), and Senn Chemicals AG, a Swiss corporation (referred to herein as “SENN”). Onyx and SENN are each sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms not otherwise defined herein shall have their respective meanings as defined in this Agreement.
